中医药防治原发性骨质疏松症专家共识(2020)

2020-12-30 中国老年学和老年医学学会 中国骨质疏松杂志.2020,26(12):1717-1725.

中国老年学和老年医学学会骨质疏松分会中医药专家委员会通过文献检索和评价,结合医师问卷调查,经专家组讨论、征求中医药专委会委员意见和咨询中医骨伤科界名老专家建议,对《中医药防治原发性骨质疏松症专家共识(

中文标题:

中医药防治原发性骨质疏松症专家共识(2020)

发布日期:

2020-12-30

简要介绍:

中国老年学和老年医学学会骨质疏松分会中医药专家委员会通过文献检索和评价,结合医师问卷调查,经专家组讨论、征求中医药专委会委员意见和咨询中医骨伤科界名老专家建议,对《中医药防治原发性骨质疏松症专家共识( 2015) 》进行了详实修订。2020 版共识内容包括: 临床表现和诊断、中医学的病因病机、治则、辨证施治、临床推荐意见、临床疗效评价和监测、治未病与健康管理等,增加了临床表现腰膝酸软、骨密度测量临床指征、骨质疏松脆性骨折诊断标准、骨质疏松症风险评估、中医病因、针灸治疗和中医证候分级量化评分标准等内容。本共识突出中医药的特色和优势,坚持中西医并重,传承精华,守正创新,旨在为临床医师防治原发性骨质疏松症和科学研究提供参考。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=中医药防治原发性骨质疏松症专家共识_2020_葛继荣.pdf)] GetToolGuiderByIdResponse(projectId=1, id=ed2b41c0020a4379, title=中医药防治原发性骨质疏松症专家共识(2020), enTitle=, guiderFrom=中国骨质疏松杂志.2020,26(12):1717-1725., authorId=0, author=, summary=中国老年学和老年医学学会骨质疏松分会中医药专家委员会通过文献检索和评价,结合医师问卷调查,经专家组讨论、征求中医药专委会委员意见和咨询中医骨伤科界名老专家建议,对《中医药防治原发性骨质疏松症专家共识(, cover=https://img.medsci.cn/2021128/1611839766523_2020535.jpg, journalId=0, articlesId=null, associationId=1751, associationName=中国老年学和老年医学学会, associationIntro=, copyright=0, guiderPublishedTime=Wed Dec 30 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>中国老年学和老年医学学会骨质疏松分会中医药专家委员会通过文献检索和评价,结合医师问卷调查,经专家组讨论、征求中医药专委会委员意见和咨询中医骨伤科界名老专家建议,对《中医药防治原发性骨质疏松症专家共识( 2015) 》进行了详实修订。2020 版共识内容包括: 临床表现和诊断、中医学的病因病机、治则、辨证施治、临床推荐意见、临床疗效评价和监测、治未病与健康管理等,增加了临床表现腰膝酸软、骨密度测量临床指征、骨质疏松脆性骨折诊断标准、骨质疏松症风险评估、中医病因、针灸治疗和中医证候分级量化评分标准等内容。本共识突出中医药的特色和优势,坚持中西医并重,传承精华,守正创新,旨在为临床医师防治原发性骨质疏松症和科学研究提供参考。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=644, tagName=骨质疏松症)], categoryList=[CategoryDto(categoryId=19, categoryName=老年医学, tenant=100), CategoryDto(categoryId=37, categoryName=中医科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21067, categoryName=梅斯医学-骨质疏松网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=644, guiderKeyword=骨质疏松症, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=11765, appHits=346, showAppHits=0, pcHits=1256, showPcHits=11419, likes=3, shares=45, comments=24, approvalStatus=1, publishedTime=Fri Jan 29 08:18:28 CST 2021, publishedTimeString=2020-12-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Thu Jan 28 21:16:17 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Thu Jan 04 02:41:21 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=中医药防治原发性骨质疏松症专家共识_2020_葛继荣.pdf)])
中医药防治原发性骨质疏松症专家共识_2020_葛继荣.pdf
下载请点击:
评论区 (17)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1221405, encodeId=07521221405f4, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=044d1613231, createdName=li2015, createdTime=Sat May 21 15:26:39 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214736, encodeId=85191214e363e, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Tue Apr 26 19:48:57 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199210, encodeId=f7211199210f0, content=值得好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24ae4013331, createdName=13a34b3dm47暂无昵称, createdTime=Thu Mar 03 22:39:50 CST 2022, time=2022-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193285, encodeId=37471193285e4, content=有实用价值,非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Mon Feb 14 12:40:21 CST 2022, time=2022-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181478, encodeId=fd3311814e826, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85885577571, createdName=ms9000001761409400, createdTime=Thu Jan 06 19:55:28 CST 2022, time=2022-01-06, status=1, ipAttribution=)]
    2022-05-21 li2015

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1221405, encodeId=07521221405f4, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=044d1613231, createdName=li2015, createdTime=Sat May 21 15:26:39 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214736, encodeId=85191214e363e, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Tue Apr 26 19:48:57 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199210, encodeId=f7211199210f0, content=值得好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24ae4013331, createdName=13a34b3dm47暂无昵称, createdTime=Thu Mar 03 22:39:50 CST 2022, time=2022-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193285, encodeId=37471193285e4, content=有实用价值,非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Mon Feb 14 12:40:21 CST 2022, time=2022-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181478, encodeId=fd3311814e826, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85885577571, createdName=ms9000001761409400, createdTime=Thu Jan 06 19:55:28 CST 2022, time=2022-01-06, status=1, ipAttribution=)]
    2022-04-26 su_yi_fei

    很实用

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1221405, encodeId=07521221405f4, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=044d1613231, createdName=li2015, createdTime=Sat May 21 15:26:39 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214736, encodeId=85191214e363e, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Tue Apr 26 19:48:57 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199210, encodeId=f7211199210f0, content=值得好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24ae4013331, createdName=13a34b3dm47暂无昵称, createdTime=Thu Mar 03 22:39:50 CST 2022, time=2022-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193285, encodeId=37471193285e4, content=有实用价值,非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Mon Feb 14 12:40:21 CST 2022, time=2022-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181478, encodeId=fd3311814e826, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85885577571, createdName=ms9000001761409400, createdTime=Thu Jan 06 19:55:28 CST 2022, time=2022-01-06, status=1, ipAttribution=)]
    2022-03-03 13a34b3dm47暂无昵称

    值得好好学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1221405, encodeId=07521221405f4, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=044d1613231, createdName=li2015, createdTime=Sat May 21 15:26:39 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214736, encodeId=85191214e363e, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Tue Apr 26 19:48:57 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199210, encodeId=f7211199210f0, content=值得好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24ae4013331, createdName=13a34b3dm47暂无昵称, createdTime=Thu Mar 03 22:39:50 CST 2022, time=2022-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193285, encodeId=37471193285e4, content=有实用价值,非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Mon Feb 14 12:40:21 CST 2022, time=2022-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181478, encodeId=fd3311814e826, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85885577571, createdName=ms9000001761409400, createdTime=Thu Jan 06 19:55:28 CST 2022, time=2022-01-06, status=1, ipAttribution=)]
    2022-02-14 ms3000000637975859

    有实用价值,非常好

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1221405, encodeId=07521221405f4, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=044d1613231, createdName=li2015, createdTime=Sat May 21 15:26:39 CST 2022, time=2022-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214736, encodeId=85191214e363e, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Tue Apr 26 19:48:57 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199210, encodeId=f7211199210f0, content=值得好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24ae4013331, createdName=13a34b3dm47暂无昵称, createdTime=Thu Mar 03 22:39:50 CST 2022, time=2022-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193285, encodeId=37471193285e4, content=有实用价值,非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Mon Feb 14 12:40:21 CST 2022, time=2022-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181478, encodeId=fd3311814e826, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85885577571, createdName=ms9000001761409400, createdTime=Thu Jan 06 19:55:28 CST 2022, time=2022-01-06, status=1, ipAttribution=)]
    2022-01-06 ms9000001761409400

    学习了

    0

拓展阅读

2017 ACP临床实践指南:治疗低骨密度或骨质疏松症预防骨折

美国医学会(AMA,American Medical Association) · 2017-05-09

2017 SIOT临床指南:骨质疏松症的预防和治疗

意大利骨科和创伤外科学会(SIOT,Italian Society for Orthopaedics and Traumatology) · 2017-10-20

2018 法国绝经后骨质疏松症的管理建议(更新版)

法国风湿病学学会(SFR,French Society for Rheumatology) · 2018-04-11

2019 TES临床实践指南:女性绝经后骨质疏松症的药物治疗

美国内分泌学会(TES,The Endocrine Society) · 2019-03-25